CLINICAL_TRIALS
trial_result
· 2014-06-18
Clinical Trial Update: Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria [Phase 3]
Summary
Phase 3 trial update discusses the efficacy and safety of omalizumab for chronic idiopathic urticaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Chronic Idiopathic Urticaria | Phase 3 | Status: UNKNOWN